Millennium Management
OMGA

Millennium Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Millennium Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-520,898
Closed -$388K – 6587
2024
Q4 		$388K Sell
520,898
-14,718
-3% -$14.7K ﹤0.01% 4922
2024
Q3 		$653K Sell
535,616
-218,607
-29% -$348K ﹤0.01% 4611
2024
Q2 		$1.56M Buy
754,223
+427,078
+131% +$1.01M ﹤0.01% 3749
2024
Q1 		$1.19M Buy
327,145
+300,713
+1,138% +$1.15M ﹤0.01% 4151
2023
Q4 		$79.6K Sell
26,432
-185,452
-88% -$376K ﹤0.01% 5391
2023
Q3 		$456K Buy
211,884
+123,987
+141% +$496K ﹤0.01% 4724
2023
Q2 		$492K Sell
87,897
-125,893
-59% -$985K ﹤0.01% 4561
2023
Q1 		$1.29M Buy
213,790
+176,787
+478% +$1.23M ﹤0.01% 3857
2022
Q4 		$211K Buy
37,003
+19,983
+117% +$112K ﹤0.01% 5303
2022
Q3 		$92K Sell
17,020
-207,553
-92% -$1.05M ﹤0.01% 5997
2022
Q2 		$853K Buy
224,573
+202,079
+898% +$752K ﹤0.01% 4521
2022
Q1 		$140K Buy
+22,494
New +$230K ﹤0.01% 6000
2021
Q4 		– Sell
-218,620
Closed -$4.12M – 7493
2021
Q3 		$4.12M Buy
+218,620
New +$4.19M ﹤0.01% 3096

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Millennium Management's OMGA Position: Q1 2025 in Review

Millennium Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 520,898 shares — an estimated $388K sold.

Millennium Management first reported a position in OMGA in Q3 2021 and held it in 13 quarters. The position peaked at $4.12M in Q3 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Millennium Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 520,898 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $388K.
  • Millennium Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 13 quarters.
  • Millennium Management's Omega Therapeutics, Inc. Common Stock position peaked at $4.12M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.